Is 68Ga-DOTA-NOC PET/CT indicated in patients with clinical, biochemical or radiological suspicion of neuroendocrine tumour?

被引：0
|
作者：
Valentina Ambrosini
Davide Campana
Cristina Nanni
Silvia Cambioli
Paola Tomassetti
Domenico Rubello
Stefano Fanti
机构：
[1] S. Orsola-Malpighi University Hospital,Nuclear Medicine
[2] S. Orsola-Malpighi University Hospital,Internal Medicine
[3] Ospedale S. Maria della Misericordia,Nuclear Medicine
[4] Azienda Ospedaliero Universitaria di Bologna,Nuclear Medicine, Pad 30
[5] Policlinico S. Orsola-Malpighi,undefined
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2012年 / 39卷
关键词：
Ga-DOTA-NOC; PET/CT; NET; Appropriate use;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1278 / 1283
页数：5
相关论文
共 50 条
  • [31] Detection of unknown primary neuroendocrine tumours (CUP-NET) using 68Ga-DOTA-NOC receptor PET/CT
    Vikas Prasad
    Valentina Ambrosini
    Merten Hommann
    Dieter Hoersch
    Stefano Fanti
    Richard P. Baum
    European Journal of Nuclear Medicine and Molecular Imaging, 2010, 37 : 67 - 77
  • [32] Preliminary experience on the use of 68Ga-DOTA-NOC PET to study patients with paraganglioma
    Ambrosini, Valentina
    Castellucci, Paolo
    Musto, Alessandra
    Allegri, Vincenzo
    Montini, Giancarlo
    Rubello, Domenico
    Nanni, Cristina
    Fanti, Stefano
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [33] Highly variable biodistribution of 68Ga labeled somatostatin analogues 68Ga-DOTA-NOC and 68Ga-DOTA-TATE in neuroendocrine tumors: clinical implications for somatostatin receptor directed PET/CT
    Cheng, Monica
    Tann, Mark
    HEPATOBILIARY SURGERY AND NUTRITION, 2022,
  • [34] Standardized uptake values of 68Ga-DOTA-NOC PET: a promosing prognostic tool in neuroendocrine tumours
    Ambrosini, V.
    Campana, D.
    Nori, F.
    Nanni, C.
    Montini, G.
    Castellucci, P.
    Allegri, V.
    Rubello, D.
    Caroli, P.
    Rizzello, A.
    Tomassetti, P.
    Franchi, R.
    Fanti, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S201 - S201
  • [35] Neuroendocrine Tumor Imaging With 68Ga-DOTA-NOC: Physiologic and Benign Variants
    Kagna, Olga
    Pirmisashvili, Natalia
    Tshori, Sagi
    Freedman, Nanette
    Israel, Ora
    Krausz, Yodphat
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2014, 203 (06) : 1317 - 1323
  • [36] Detection of unknown primary neuroendocrine tumours (CUP-NET) using 68Ga-DOTA-NOC receptor PET/CT
    Prasad, Vikas
    Ambrosini, Valentina
    Hommann, Merten
    Hoersch, Dieter
    Fanti, Stefano
    Baum, Richard P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 (01) : 67 - 77
  • [37] A head-to-head comparison study of 68Ga-DOTA-Exendin-4 and 68Ga-DOTA-NOC PET/CT in insulinomas.
    ArunRaj, S.
    Damle, Nishikant
    Gupta, Yashdeep
    Pal, Sujoy
    Sharma, Mehar
    Tripathi, Madhavi
    Kumar, Rajeev
    Ballal, Sanjana
    Yadav, Madhav
    Bal, Chandrasekhar
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [38] Role of 68Ga-DOTA-NOC receptor PET/CT in the detection of unknown primary metastatic neuroendocrine tumors (CUP-NET)
    Naswa, Niraj
    Soundar, Ramya
    Kumar, Rakesh
    Bal, Chandrasekhar
    Malhotra, Arun
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [39] Appropriate use of 68Ga-DOTANOC PET/CT in patients with biochemical/clinical/radiological suspicion of NET
    Ambrosini, Valentina
    Nicolini, Silvia
    Nanni, Cristina
    Cambioli, Silvia
    Campana, Davide
    Allegri, Vincenzo
    Montini, Gian Carlo
    Tomassetti, Paola
    Fanti, Stefano
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [40] Small cell lung cancer mimicking lymphoma in CT and 68Ga-DOTA-NOC PET/CT A case report
    Lu, Liyan
    Li, Fengfang
    Zhang, Yamei
    Wang, Peng
    Yin, Xindao
    Li, Wenbin
    MEDICINE, 2018, 97 (25)
12345